Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2017

01-08-2017 | Original Article

A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis

Authors: Ganesh Pantham, Anthony Post, Deepak Venkat, Douglas Einstadter, Kevin D. Mullen

Published in: Digestive Diseases and Sciences | Issue 8/2017

Login to get access

Abstract

Background and Aims

Overt hepatic encephalopathy (HE) is a major cause of significant morbidity and mortality in patients with liver cirrhosis. We examined the frequency and profile of the precipitating factors resulting in hospitalizations for overt HE.

Methods

We conducted both retrospective and prospective studies to identify clinical precipitants of overt HE in patients with cirrhosis. The retrospective study patients were hospitalized at a large urban safety-net hospital, and the prospective study included the patients admitted at a liver transplant center.

Results

There were a total of 149 patients with cirrhosis and overt HE (91 males, mean age 55.3 ± 8.6 years) in the retrospective group and 45 patients (27 males, mean age 58.3 ± 8.2 years) in the prospective group of the study. The average MELD score was 16 ± 6.8 in the retrospective group and 22.7 ± 7.2 in the prospective group. Dehydration (46–76%), acute kidney injury (32–76%), lactulose nonadherence (about 50%), constipation (about 40%), and infections (20–42%) were the most frequently identified precipitants for hospitalization in retrospective and prospective groups. Multiple precipitants were identified in 60 (40.3%) patients in the retrospective group and 34 (76%) patients in the prospective group.

Conclusions

Multiple concurrent precipitating factors were identified in the majority of patients with overt HE requiring hospitalization. Dehydration due to various causes was the most common precipitant of overt HE, followed by acute kidney injury (AKI), constipation, and infections. Prevention of dehydration, AKI, and constipation by close outpatient monitoring may be an effective measure to prevent hospitalization for overt HE in patients with cirrhosis.
Literature
1.
go back to reference Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014–2021.CrossRefPubMed Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014–2021.CrossRefPubMed
2.
go back to reference Riggio O, Efrati C, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology. 2005;42:1158–1165.CrossRefPubMed Riggio O, Efrati C, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology. 2005;42:1158–1165.CrossRefPubMed
3.
go back to reference Ferenci P, Lockwood A, Mullen KD, et al. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification-final report of the working party at the 11th world congress of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721.CrossRefPubMed Ferenci P, Lockwood A, Mullen KD, et al. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification-final report of the working party at the 11th world congress of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721.CrossRefPubMed
4.
go back to reference Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005;42:S45–S53.CrossRefPubMed Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005;42:S45–S53.CrossRefPubMed
5.
go back to reference Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther. 2007;25:3–9.CrossRefPubMed Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther. 2007;25:3–9.CrossRefPubMed
6.
7.
go back to reference Norenberg MD. Astrocyte-ammonia interactions in hepatic encephalopathy. Semin Liver Dis. 1996;16:245–253.CrossRefPubMed Norenberg MD. Astrocyte-ammonia interactions in hepatic encephalopathy. Semin Liver Dis. 1996;16:245–253.CrossRefPubMed
8.
go back to reference Bernal W, Hall C, Karvellas CJ, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844–1852.CrossRefPubMed Bernal W, Hall C, Karvellas CJ, et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844–1852.CrossRefPubMed
9.
go back to reference Jones EA, Mullen KD. Theories of the pathogenesis of hepatic encephalopathy. Clin Liver Dis. 2012;16:7–26.CrossRefPubMed Jones EA, Mullen KD. Theories of the pathogenesis of hepatic encephalopathy. Clin Liver Dis. 2012;16:7–26.CrossRefPubMed
10.
go back to reference Cichoż-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol. 2013;19:26–34.CrossRefPubMedPubMedCentral Cichoż-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol. 2013;19:26–34.CrossRefPubMedPubMedCentral
11.
go back to reference Conn HO, Liberthal MM. The Hepatic coma syndromes and lactulose. Management of acute portosystemic encephalopathy. Baltimore: Williams and Wilkins; 1979:189–219. Conn HO, Liberthal MM. The Hepatic coma syndromes and lactulose. Management of acute portosystemic encephalopathy. Baltimore: Williams and Wilkins; 1979:189–219.
12.
go back to reference Tromn A, Griga T, Greving I, et al. Hepatic encephalopathy in patients with cirrhosis and upper GI bleeding. Hepatology. 2000;47:473–477. Tromn A, Griga T, Greving I, et al. Hepatic encephalopathy in patients with cirrhosis and upper GI bleeding. Hepatology. 2000;47:473–477.
13.
go back to reference Bianchi GP, Marchesini G, Fabbri A, et al. Vegetables versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized crossover comparison. J Int Med. 1993;233:385–392.CrossRef Bianchi GP, Marchesini G, Fabbri A, et al. Vegetables versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized crossover comparison. J Int Med. 1993;233:385–392.CrossRef
14.
go back to reference Strauss E, de Sá MFG. Bacterial infections associated with hepatic encephalopathy: prevalence and outcome. Ann Hepatol. 2003;2:41–45.PubMed Strauss E, de Sá MFG. Bacterial infections associated with hepatic encephalopathy: prevalence and outcome. Ann Hepatol. 2003;2:41–45.PubMed
15.
go back to reference Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia: Saunders; 1964:50–64. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The liver and portal hypertension. Philadelphia: Saunders; 1964:50–64.
16.
go back to reference Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.CrossRefPubMed Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.CrossRefPubMed
17.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.CrossRefPubMed
18.
go back to reference Wolf D, Anand BS, Lee JG: Hepatic encephalopathy. emedicine.medscape.com/article/186101-overview. Nov, 2014. Wolf D, Anand BS, Lee JG: Hepatic encephalopathy. emedicine.medscape.com/article/186101-overview. Nov, 2014.
19.
go back to reference Bajaj JS, Sanyal AJ, Bell D, et al. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther. 2010;31:1012–1017.CrossRefPubMed Bajaj JS, Sanyal AJ, Bell D, et al. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther. 2010;31:1012–1017.CrossRefPubMed
20.
go back to reference Guevara M, Baccaro ME, Ríos J, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int. 2010;30:1137–1142.CrossRefPubMed Guevara M, Baccaro ME, Ríos J, et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int. 2010;30:1137–1142.CrossRefPubMed
21.
go back to reference Guevara M, Baccaro ME, Torre A, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol. 2009;104:1382–1389.CrossRefPubMed Guevara M, Baccaro ME, Torre A, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol. 2009;104:1382–1389.CrossRefPubMed
22.
go back to reference Van Thiel DH, Fagiuoli S, Wright HI, et al. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology. 1994;19:67–71.CrossRefPubMed Van Thiel DH, Fagiuoli S, Wright HI, et al. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology. 1994;19:67–71.CrossRefPubMed
23.
go back to reference Bouin M, Vincent C, Bouhier K, et al. Increased oro-cecal transit time in grade I or II hepatic encephalopathy. Gastroenterol Clin Biol. 2004;28:1240–1244.CrossRefPubMed Bouin M, Vincent C, Bouhier K, et al. Increased oro-cecal transit time in grade I or II hepatic encephalopathy. Gastroenterol Clin Biol. 2004;28:1240–1244.CrossRefPubMed
24.
go back to reference Gayatri AA, Suryadharma IG, Purwadi N, et al. The relationship between a model of end stage liver disease score (MELD score) and the occurrence of spontaneous bacterial peritonitis in liver cirrhotic patients. Acta Med Indones. 2007;39:75–78.PubMed Gayatri AA, Suryadharma IG, Purwadi N, et al. The relationship between a model of end stage liver disease score (MELD score) and the occurrence of spontaneous bacterial peritonitis in liver cirrhotic patients. Acta Med Indones. 2007;39:75–78.PubMed
25.
go back to reference Nguyen LD, Morgan T. Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view. Hepatol Int. 2014;8:447–451.CrossRefPubMed Nguyen LD, Morgan T. Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view. Hepatol Int. 2014;8:447–451.CrossRefPubMed
26.
go back to reference Kalaitzakis E, Olsson R, Henfridsson P, et al. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int. 2007;27:1194–1201.PubMed Kalaitzakis E, Olsson R, Henfridsson P, et al. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int. 2007;27:1194–1201.PubMed
27.
go back to reference Borhofen SM, Gerner C, Lehmann J, et al. The Royal Free Hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis. Dig Dis Sci. 2016;61:1735–1743.CrossRefPubMed Borhofen SM, Gerner C, Lehmann J, et al. The Royal Free Hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis. Dig Dis Sci. 2016;61:1735–1743.CrossRefPubMed
28.
go back to reference Merli M, Iebba V, Giusto M. What is new about diet in hepatic encephalopathy. Metab Brain Dis. 2016;31:1289–1294.CrossRefPubMed Merli M, Iebba V, Giusto M. What is new about diet in hepatic encephalopathy. Metab Brain Dis. 2016;31:1289–1294.CrossRefPubMed
30.
go back to reference Sigal SH, Stanca CM, Kontorinis N, et al. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol. 2006;101:1490–1496.CrossRefPubMed Sigal SH, Stanca CM, Kontorinis N, et al. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol. 2006;101:1490–1496.CrossRefPubMed
31.
go back to reference Elkrief L, Chouinard P, Bendersky N, et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology. 2014;60:823–831.CrossRefPubMed Elkrief L, Chouinard P, Bendersky N, et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology. 2014;60:823–831.CrossRefPubMed
32.
go back to reference Liu TL, Trogdon J, Weinberger M, Fried B, et al. Diabetes is associated with clinical decompensation events in patients with cirrhosis. Dig Dis Sci. 2016;61:3335–3345.CrossRefPubMed Liu TL, Trogdon J, Weinberger M, Fried B, et al. Diabetes is associated with clinical decompensation events in patients with cirrhosis. Dig Dis Sci. 2016;61:3335–3345.CrossRefPubMed
33.
go back to reference Mumtaz K, Ahmed US, Abid S, et al. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physicians Surg Pak. 2010;20:514–518.PubMed Mumtaz K, Ahmed US, Abid S, et al. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physicians Surg Pak. 2010;20:514–518.PubMed
34.
go back to reference Wang QM, Ji Q, Duan ZJ, et al. A study on the position and etiology of infection in cirrhotic patients: a potential precipitating factor contributing to hepatic encephalopathy. Exp Ther Med. 2013;6:584–590.PubMedPubMedCentral Wang QM, Ji Q, Duan ZJ, et al. A study on the position and etiology of infection in cirrhotic patients: a potential precipitating factor contributing to hepatic encephalopathy. Exp Ther Med. 2013;6:584–590.PubMedPubMedCentral
35.
go back to reference Volk ML, Tocco RS, Bazick J, et al. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247–252.CrossRefPubMed Volk ML, Tocco RS, Bazick J, et al. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247–252.CrossRefPubMed
Metadata
Title
A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis
Authors
Ganesh Pantham
Anthony Post
Deepak Venkat
Douglas Einstadter
Kevin D. Mullen
Publication date
01-08-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4630-y

Other articles of this Issue 8/2017

Digestive Diseases and Sciences 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.